| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vision Disorders | D014786 | 10 associated lipids |
| Multiple Myeloma | D009101 | 13 associated lipids |
| Osteoporosis | D010024 | 12 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Otosclerosis | D010040 | 2 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Calcinosis | D002114 | 5 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lu J et al. | Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. | 2016 | Exp. Biol. Med. (Maywood) | pmid:26908571 |
| Chen H et al. | [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. | 2016 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:28070039 |
| Zhang YY et al. | Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. | 2016 | Chin J Dent Res | pmid:27379348 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
| Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| Kao SY and Stankovic KM | Transactivation of human osteoprotegerin promoter by GATA-3. | 2015 | Sci Rep | pmid:26216189 |
| Recker EN et al. | A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. | 2015 | J. Periodontol. | pmid:25269523 |